Pacific Biosciences Posts Higher Loss on Increased Costs, Reports $20M Backlog

The firm said that its order backlog includes 32 PacBio RS systems. It anticipates a commercial launch of the system in the first half of 2011.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories